These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7684443)

  • 61. Actions of typical and atypical antipsychotics on tuberoinfundibular dopamine neurons.
    Gudelsky GA; Berry SA; Meltzer HY
    Psychopharmacol Bull; 1989; 25(3):377-82. PubMed ID: 2576317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
    He H; Richardson JS
    Int Clin Psychopharmacol; 1995 Mar; 10(1):19-30. PubMed ID: 7542676
    [TBL] [Abstract][Full Text] [Related]  

  • 64. D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors.
    Qin ZH; Zhou LW; Weiss B
    Neuroscience; 1994 May; 60(1):97-114. PubMed ID: 8052421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats.
    Rosengarten H; Quartermain D
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1047-54. PubMed ID: 12452525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
    Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
    J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clozapine and D1/D2 antagonism in extrapyramidal functions.
    Gerlach J; Hansen L
    Br J Psychiatry Suppl; 1992 May; (17):34-7. PubMed ID: 1418886
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy.
    Sumiyoshi T; Suzuki K; Sakamoto H; Yamaguchi N; Mori H; Shiba K; Yokogawa K
    Neuropsychopharmacology; 1995 Feb; 12(1):57-64. PubMed ID: 7766287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Time course of dopamine-D2 and serotonin-5-HT2 receptor occupancy rates by haloperidol and clozapine in vivo.
    Sumiyoshi T; Kido H; Sakamoto H; Urasaki K; Suzuki K; Yamaguchi N; Mori H; Shiba K; Yokogawa K; Ichimura F
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):131-7. PubMed ID: 8411785
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.
    Lee H; Tarazi FI; Chakos M; Wu H; Redmond M; Alvir JM; Kinon BJ; Bilder R; Creese I; Lieberman JA
    Life Sci; 1999; 64(18):1595-602. PubMed ID: 10328519
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).
    Strupczewski JT; Bordeau KJ; Chiang Y; Glamkowski EJ; Conway PG; Corbett R; Hartman HB; Szewczak MR; Wilmot CA; Helsley GC
    J Med Chem; 1995 Mar; 38(7):1119-31. PubMed ID: 7707315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular combination of the dopamine and serotonin scaffolds yield in novel antipsychotic drug candidates - characterization by in vivo experiments.
    Schulze M; Siol O; Robaa D; Mueller FK; Enzensperger C; Fleck C; Lehmann J
    Arzneimittelforschung; 2012 May; 62(5):252-60. PubMed ID: 22488415
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contrasting loxapine to its isomer isoloxapine--the critical role of in vivo D2 blockade in determining atypicality.
    Natesan S; Vanderspek S; Nobrega JN; McClelland RA; Kapur S
    Schizophr Res; 2005 Sep; 77(2-3):189-99. PubMed ID: 15925489
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis.
    Kusumi I; Boku S; Takahashi Y
    Psychiatry Clin Neurosci; 2015 May; 69(5):243-58. PubMed ID: 25296946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.
    Roth BL; Tandra S; Burgess LH; Sibley DR; Meltzer HY
    Psychopharmacology (Berl); 1995 Aug; 120(3):365-8. PubMed ID: 8524985
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.
    Kapur S; Remington G; Zipursky RB; Wilson AA; Houle S
    Life Sci; 1995; 57(10):PL103-7. PubMed ID: 7543969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
    Dugovic C; Wauquier A; Janssen PA
    Neuropharmacology; 1989 Dec; 28(12):1431-3. PubMed ID: 2482460
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats.
    Panocka I; Ciccocioppo R; Pompei P; Massi M
    Pharmacol Biochem Behav; 1993 Dec; 46(4):853-6. PubMed ID: 7508629
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used.
    Schotte A; Bonaventure P; Janssen PF; Leysen JE
    Jpn J Pharmacol; 1995 Dec; 69(4):399-412. PubMed ID: 8786644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risperidone, a new antipsychotic with serotonin 5-HT2 and dopamine D2 antagonistic properties.
    Heylen SL; Gelders YG
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():180A-181A. PubMed ID: 1379877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.